Lexaria Stock Based Compensation from 2010 to 2025

LEXX Stock

USD 1.72 0.03 1.71%

Lexaria Bioscience Stock Based Compensation yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation will likely drop to about 538.4 K in 2025. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2008-02-29

Previous Quarter

96.5 K

Current Value

99.4 K

Quarterly Volatility

318.6 K

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 129 K, Interest Expense of 107.8 K or Other Operating Expenses of 7.5 M, as well as many indicators such as Price To Sales Ratio of 140, Dividend Yield of 0.0 or PTB Ratio of 57.61. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.

Check out the analysis of Lexaria Bioscience Correlation against competitors.

Latest Lexaria Bioscience's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Lexaria Bioscience Corp over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Lexaria Bioscience's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Lexaria Stock Based Compensation Regression Statistics

	Arithmetic Mean	560,170
	Geometric Mean	327,449
	Coefficient Of Variation	111.93
	Mean Deviation	393,342
	Median	492,236
	Standard Deviation	626,985
	Sample Variance	393.1B
	Range	2.6M
	R-Value	0.17
	Mean Square Error	408.3B
	R-Squared	0.03
	Significance	0.52
	Slope	23,029
	Total Sum of Squares	5.9T

Lexaria Stock Based Compensation History

	2025	538.4 K
	2024	566.1 K
	2023	492.2 K
	2022	170.4 K
	2021	752.6 K
	2020	410 K
	2019	1.1 M

Other Fundumenentals of Lexaria Bioscience Corp

Stock Based Compensation To Revenue

Lexaria Bioscience Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Common Stock	Current Deferred Revenue	Net Receivables	Short Term Debt	Intangible Assets	Net Tangible Assets	Net Invested Capital	Net Working Capital	Property Plant Equipment	Short Term Investments	Capital Stock	Long Term Debt	Short Long Term Debt
Total Assets		0.99	-0.89	-0.71	0.64	0.28	0.96	-0.58	-0.45	0.44	-0.23	0.78	0.84	0.91	0.89	0.56	0.66	-0.82	-0.52	-0.52
Total Stockholder Equity	0.99		-0.94	-0.73	0.59	0.15	0.99	-0.55	-0.51	0.43	-0.31	0.79	0.88	0.93	0.91	0.58	0.72	-0.84	-0.49	-0.49
Net Debt	-0.89	-0.94		0.7	-0.46	0.12	-0.97	0.41	0.52	-0.35	0.43	-0.72	-0.87	-0.93	-0.92	-0.56	-0.77	0.79	0.33	0.33
Retained Earnings	-0.71	-0.73	0.7		-0.69	-0.09	-0.75	0.34	0.44	-0.38	0.6	-0.97	-0.68	-0.59	-0.51	-0.75	-0.32	0.84	0.45	0.45
Accounts Payable	0.64	0.59	-0.46	-0.69		0.42	0.62	-0.45	0.11	0.0	-0.24	0.74	0.4	0.44	0.39	0.35	-0.1	-0.59	-0.79	-0.79
Total Liab	0.28	0.15	0.12	-0.09	0.42		0.05	-0.43	0.16	0.17	0.4	0.12	0.09	0.12	0.1	-0.03	-0.18	-0.12	-0.15	-0.15
Total Current Assets	0.96	0.99	-0.97	-0.75	0.62	0.05		-0.49	-0.46	0.38	-0.39	0.8	0.86	0.92	0.9	0.57	0.68	-0.84	-0.52	-0.52
Common Stock	-0.58	-0.55	0.41	0.34	-0.45	-0.43	-0.49		0.55	0.14	-0.28	-0.42	-0.67	-0.59	-0.58	0.0	-0.38	0.74	0.3	0.3
Current Deferred Revenue	-0.45	-0.51	0.52	0.44	0.11	0.16	-0.46	0.55		-0.25	0.18	-0.43	-0.76	-0.56	-0.54	-0.32	-0.77	0.73	-0.12	-0.12
Net Receivables	0.44	0.43	-0.35	-0.38	0.0	0.17	0.38	0.14	-0.25		-0.2	0.39	0.33	0.34	0.31	0.63	0.47	-0.22	-0.01	-0.01
Short Term Debt	-0.23	-0.31	0.43	0.6	-0.24	0.4	-0.39	-0.28	0.18	-0.2		-0.47	-0.28	-0.26	-0.22	-0.45	-0.2	0.33	0.18	0.18
Intangible Assets	0.78	0.79	-0.72	-0.97	0.74	0.12	0.8	-0.42	-0.43	0.39	-0.47		0.68	0.63	0.56	0.77	0.34	-0.86	-0.59	-0.59
Net Tangible Assets	0.84	0.88	-0.87	-0.68	0.4	0.09	0.86	-0.67	-0.76	0.33	-0.28	0.68		0.93	0.91	0.48	0.81	-0.9	-0.2	-0.2
Net Invested Capital	0.91	0.93	-0.93	-0.59	0.44	0.12	0.92	-0.59	-0.56	0.34	-0.26	0.63	0.93		0.99	0.46	0.8	-0.79	-0.26	-0.26
Net Working Capital	0.89	0.91	-0.92	-0.51	0.39	0.1	0.9	-0.58	-0.54	0.31	-0.22	0.56	0.91	0.99		0.38	0.82	-0.75	-0.23	-0.23
Property Plant Equipment	0.56	0.58	-0.56	-0.75	0.35	-0.03	0.57	0.0	-0.32	0.63	-0.45	0.77	0.48	0.46	0.38		0.4	-0.49	-0.26	-0.26
Short Term Investments	0.66	0.72	-0.77	-0.32	-0.1	-0.18	0.68	-0.38	-0.77	0.47	-0.2	0.34	0.81	0.8	0.82	0.4		-0.59	0.07	0.07
Capital Stock	-0.82	-0.84	0.79	0.84	-0.59	-0.12	-0.84	0.74	0.73	-0.22	0.33	-0.86	-0.9	-0.79	-0.75	-0.49	-0.59		0.42	0.42
Long Term Debt	-0.52	-0.49	0.33	0.45	-0.79	-0.15	-0.52	0.3	-0.12	-0.01	0.18	-0.59	-0.2	-0.26	-0.23	-0.26	0.07	0.42		1.0
Short Long Term Debt	-0.52	-0.49	0.33	0.45	-0.79	-0.15	-0.52	0.3	-0.12	-0.01	0.18	-0.59	-0.2	-0.26	-0.23	-0.26	0.07	0.42	1.0

Click cells to compare fundamentals

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Stock Based Compensation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Stock Based Compensation	566.1 K	538.4 K
Stock Based Compensation To Revenue	0.75	0.71

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Lexaria Stock Based Compensation from 2010 to 2025

Latest Lexaria Bioscience's Stock Based Compensation Growth Pattern

Lexaria Stock Based Compensation Regression Statistics

Lexaria Stock Based Compensation History

Other Fundumenentals of Lexaria Bioscience Corp

Lexaria Bioscience Stock Based Compensation component correlations

About Lexaria Bioscience Financial Statements

Also Currently Popular

Additional Tools for Lexaria Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY